TrialBlood2021

Heat shock factor 1 (HSF1-pSer326) predicts response to bortezomib-containing chemotherapy in pediatric AML: a COG report.

Fieke W Hoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.